Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YYD601 vs Nexium in Erosive Esophagitis
NCT03943992Phase 3Completed
- Sponsor
- Yooyoung Pharmaceutical
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YYD601 in erosive esophagitis (EE), sponsored by Yooyoung Pharmaceutical. Started Jan 2019; status: completed.
02
Drugs
YYD601
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT03943992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943992.